World News | Jeff Stone, Bloomberg | Tuesday June 21, 2022
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
www.ndtv.com